Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Travere Therapeutics Inc (NASDAQ: TVTX) closed at $17.92 down -8.94% from its previous closing price of $19.68. In other words, the price has decreased by -$8.94 from its previous closing price. On the day, 2.58 million shares were traded. TVTX stock price reached its highest trading level at $19.25 during the session, while it also had its lowest trading level at $17.455.
Ratios:
For a deeper understanding of Travere Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.04 and its Current Ratio is at 2.08. In the meantime, Its Debt-to-Equity ratio is 6.80 whereas as Long-Term Debt/Eq ratio is at 5.54.
On October 21, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $9 to $27.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 12 ’25 when ROTE WILLIAM E. sold 5,200 shares for $23.53 per share. The transaction valued at 122,356 led to the insider holds 98,519 shares of the business.
REED ELIZABETH E sold 8,000 shares of TVTX for $188,240 on Feb 12 ’25. The SVP, GC & CORPORATE SECRETARY now owns 89,482 shares after completing the transaction at $23.53 per share. On Feb 11 ’25, another insider, Calvin Sandra, who serves as the SVP, CHIEF ACCOUNTING OFFICER of the company, sold 54,244 shares for $25.00 each. As a result, the insider received 1,356,100 and left with 54,410 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1746398848 and an Enterprise Value of 1621100672. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.82 while its Price-to-Book (P/B) ratio in mrq is 26.53. Its current Enterprise Value per Revenue stands at 6.952 whereas that against EBITDA is -7.624.
Stock Price History:
The Beta on a monthly basis for TVTX is 0.80, which has changed by 1.5454545 over the last 52 weeks, in comparison to a change of 0.077997446 over the same period for the S&P500. Over the past 52 weeks, TVTX has reached a high of $25.29, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is -13.25%, while the 200-Day Moving Average is calculated to be 15.34%.
Shares Statistics:
For the past three months, TVTX has traded an average of 1.60M shares per day and 1668510 over the past ten days. A total of 87.45M shares are outstanding, with a floating share count of 87.41M. Insiders hold about 1.50% of the company’s shares, while institutions hold 109.22% stake in the company. Shares short for TVTX as of 1741910400 were 11194840 with a Short Ratio of 6.99, compared to 1739491200 on 11301636. Therefore, it implies a Short% of Shares Outstanding of 11194840 and a Short% of Float of 13.949998999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
